French-based bioMérieux Inc., a manufacturer of patient health diagnostics solutions, will invest $48.3 million over the next three years to expand its facility in Durham County, North Carolina, with plans to create 44 jobs in the region.
The firm’s products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. The company currently employs more than 630 people at its Durham, North Carolina, facility.
“bioMérieux has a long and treasured history with North Carolina, its skilled and educated workforce has enabled us to become a leading innovator and supplier of diagnostic equipment,” said Marc Mackowiak, president and chief executive officer of bioMérieux Inc. “I applaud the One North Carolina Fund, it is a forward thinking initiative that will drive infrastructure and economic development in our state.”
The project was made possible in part by a performance-based grant from the One North Carolina Fund of up to $220,000. The grant is contingent upon proof of job creation and receipt of a local funding match. “Companies are choosing to invest in our state because of our state’s strong workforce,” said Gov. Pat McCrory. “This announcement strengthens North Carolina’s position as a leader in bioscience and advanced manufacturing.”
“The N.C. Department of Commerce is committed to working with companies to spur job creation,” said Sharon Decker, N.C. Secretary of Commerce. “We congratulate bioMérieux for investing in North Carolina once again.”